196 related articles for article (PubMed ID: 22968678)
1. Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP; van der Horst IC; Lipsic E; van der Harst P; van der Horst-Schrivers AN; Wolffenbuttel BH; de Boer RA; van Rossum AC; van Veldhuisen DJ; de Smet BJ;
Cardiovasc Drugs Ther; 2012 Oct; 26(5):417-26. PubMed ID: 22968678
[TBL] [Abstract][Full Text] [Related]
2. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
Lexis CP; van der Horst IC; Lipsic E; Wieringa WG; de Boer RA; van den Heuvel AF; van der Werf HW; Schurer RA; Pundziute G; Tan ES; Nieuwland W; Willemsen HM; Dorhout B; Molmans BH; van der Horst-Schrivers AN; Wolffenbuttel BH; ter Horst GJ; van Rossum AC; Tijssen JG; Hillege HL; de Smet BJ; van der Harst P; van Veldhuisen DJ;
JAMA; 2014 Apr; 311(15):1526-35. PubMed ID: 24687169
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial.
Haver VG; Hartman MH; Mateo Leach I; Lipsic E; Lexis CP; van Veldhuisen DJ; van Gilst WH; van der Horst IC; van der Harst P
Clin Res Cardiol; 2015 Oct; 104(10):812-21. PubMed ID: 25840550
[TBL] [Abstract][Full Text] [Related]
4. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.
Eppinga RN; Hartman MH; van Veldhuisen DJ; Lexis CP; Connelly MA; Lipsic E; van der Horst IC; van der Harst P; Dullaart RP
PLoS One; 2016; 11(1):e0145719. PubMed ID: 26808474
[TBL] [Abstract][Full Text] [Related]
5. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].
Paneni F; Costantino S; Cosentino F
G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758
[TBL] [Abstract][Full Text] [Related]
6. Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.
Eppinga RN; Kofink D; Dullaart RP; Dalmeijer GW; Lipsic E; van Veldhuisen DJ; van der Horst IC; Asselbergs FW; van der Harst P
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100626
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.
Al Ali L; Hartman MT; Lexis CP; Hummel YM; Lipsic E; van Melle JP; van Veldhuisen DJ; Voors AA; van der Horst IC; van der Harst P
PLoS One; 2016; 11(12):e0168340. PubMed ID: 27977774
[TBL] [Abstract][Full Text] [Related]
8. Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT.
Hartman MHT; Prins JKB; Schurer RAJ; Lipsic E; Lexis CPH; van der Horst-Schrivers ANA; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Clin Res Cardiol; 2017 Dec; 106(12):939-946. PubMed ID: 28755285
[TBL] [Abstract][Full Text] [Related]
9. Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial.
Posma RA; Lexis CP; Lipsic E; Nijsten MW; Damman K; Touw DJ; van Veldhuisen DJ; van der Harst P; van der Horst IC
Cardiovasc Drugs Ther; 2015; 29(5):451-9. PubMed ID: 27656713
[TBL] [Abstract][Full Text] [Related]
10. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
de Koning MLY; Westenbrink BD; Assa S; Garcia E; Connelly MA; van Veldhuisen DJ; Dullaart RPF; Lipsic E; van der Harst P
J Am Coll Cardiol; 2021 Oct; 78(14):1421-1432. PubMed ID: 34593124
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
12. Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial.
de Koning ML; van Dorp P; Assa S; Hartman MH; Voskuil M; Anthonio RL; Veen D; Pundziute-Do Prado G; Leiner T; van Goor H; van der Meer P; van Veldhuisen DJ; Nijveldt R; Lipsic E; van der Harst P
Am Heart J; 2022 Jan; 243():167-176. PubMed ID: 34534493
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
van der Schaaf RJ; Claessen BE; Hoebers LP; Verouden NJ; Koolen JJ; Suttorp MJ; Barbato E; Bax M; Strauss BH; Olivecrona GK; Tuseth V; Glogar D; Råmunddal T; Tijssen JG; Piek JJ; Henriques JP;
Trials; 2010 Sep; 11():89. PubMed ID: 20858263
[TBL] [Abstract][Full Text] [Related]
14. Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial.
Khiali S; Taban-Sadeghi M; Sarbakhsh P; Khezerlouy-Aghdam N; Namdar H; Salehi R; Rezagholizadeh A; Entezari-Maleki T
Trials; 2023 Oct; 24(1):645. PubMed ID: 37803449
[TBL] [Abstract][Full Text] [Related]
15. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
[TBL] [Abstract][Full Text] [Related]
16. The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial.
Lexis CP; van der Horst-Schrivers AN; Lipsic E; Valente MA; Muller Kobold AC; de Boer RA; van Veldhuisen DJ; van der Harst P; van der Horst IC
BMJ Open Diabetes Res Care; 2015; 3(1):e000090. PubMed ID: 26688733
[TBL] [Abstract][Full Text] [Related]
17. Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trial.
Minamino T; Toba K; Higo S; Nakatani D; Hikoso S; Umegaki M; Yamamoto K; Sawa Y; Aizawa Y; Komuro I;
Cardiovasc Drugs Ther; 2012 Oct; 26(5):409-16. PubMed ID: 22940818
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
19. Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis.
Basnet S; Kozikowski A; Makaryus AN; Pekmezaris R; Zeltser R; Akerman M; Lesser M; Wolf-Klein G
J Am Heart Assoc; 2015 Oct; 4(10):e002314. PubMed ID: 26494519
[TBL] [Abstract][Full Text] [Related]
20. Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial).
Gorter TM; Lexis CP; Hummel YM; Lipsic E; Nijveldt R; Willems TP; van der Horst IC; van der Harst P; van Melle JP; van Veldhuisen DJ
Am J Cardiol; 2016 Aug; 118(3):338-44. PubMed ID: 27265672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
